Reducing bloodstream infections from central lines
Part of Infections clinical trials.
This study aims to reduce infections that can happen when you have a central line, which is a special tube placed in a large vein to give medicines or fluids. It will test ways to improve care for patients with these lines to prevent infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a central line in place for at least 24 hours.
- You are not a hospice patient.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This study looks at ways to better treat central line infections that are hard to cure because of bacteria that stick to the tube. It may help find a treatment that works better for patients in intensive care.
This study uses special genetic testing of bacteria from blood to figure out where central-line bloodstream infections come from. Results may help doctors better identify the source and improve prevention and treatment.
This study tests a catheter lock solution called DefenCath (taurolidine and heparin) against a standard heparin lock to see if it reduces central line bloodstream infections in people receiving IV nutrition (total parenteral nutrition) for more than 3 months.
Hear when a new Central Line-associated Bloodstream Infection (CLABSI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.